221 related articles for article (PubMed ID: 6337218)
1. T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study.
Harrist TJ; Muhlbauer JE; Murphy GF; Mihm MC; Bhan AK
J Invest Dermatol; 1983 Feb; 80(2):100-3. PubMed ID: 6337218
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous detection of T6 and HLA-DR antigens distinguishes three cell subpopulations in dispersed normal human epidermal cells.
Dezutter-Dambuyant C; Faure M; Schmitt D; Laquoi C; Thivolet J
Immunol Lett; 1984; 7(4):203-7. PubMed ID: 6423529
[TBL] [Abstract][Full Text] [Related]
3. Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies.
Guzman de Fleury M; Tapia FJ; Soto J; Ghersi N; Convit J
Histol Histopathol; 1986 Jul; 1(3):227-34. PubMed ID: 2856536
[TBL] [Abstract][Full Text] [Related]
4. Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens).
Hanau D; Fabre M; Schmitt DA; Garaud JC; Pauly G; Tongio MM; Mayer S; Cazenave JP
Proc Natl Acad Sci U S A; 1987 May; 84(9):2901-5. PubMed ID: 3106979
[TBL] [Abstract][Full Text] [Related]
5. In situ identification of T6-positive cells in normal human dermis by immunoelectron microscopy.
Murphy GF; Bhan AK; Harrist TJ; Mihm MC
Br J Dermatol; 1983 Apr; 108(4):423-31. PubMed ID: 6687687
[TBL] [Abstract][Full Text] [Related]
6. Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells.
Czernielewski JM; Schmitt D; Faure MR; Thivolet J
Br J Dermatol; 1983 Feb; 108(2):129-38. PubMed ID: 6186266
[TBL] [Abstract][Full Text] [Related]
7. Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration.
Haftek M; Faure M; Schmitt D; Thivolet J
J Invest Dermatol; 1983 Jul; 81(1):10-4. PubMed ID: 6345681
[TBL] [Abstract][Full Text] [Related]
8. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study.
Drijkoningen M; De Wolf-Peeters C; van den Oord JJ; Degreef H; Desmet V
Arch Pathol Lab Med; 1986 Apr; 110(4):321-5. PubMed ID: 2420303
[TBL] [Abstract][Full Text] [Related]
9. Location of HLA-A,B,C antigens in dendritic cells of normal human skin: an immunoelectron microscopic study.
Bronstein BR; Murphy GF; Harrist TJ; Ruiter DJ; Mihm MC; Bhan AK
J Invest Dermatol; 1983 Jun; 80(6):481-4. PubMed ID: 6343512
[TBL] [Abstract][Full Text] [Related]
10. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects.
de Jong MC; Blanken R; Nanninga J; Van Voorst Vader PC; Poppema S
J Invest Dermatol; 1986 Dec; 87(6):698-702. PubMed ID: 2431069
[TBL] [Abstract][Full Text] [Related]
11. Comparison between the L-DOPA histofluorescence procedure and the indirect immunofluorescence with anti-T6 and -HLA-DR monoclonal antibodies in visualizing Langerhans cells of human epidermis.
Crivellato E; Damiani D; Mallardi F
Acta Histochem; 1990; 88(1):59-64. PubMed ID: 2113342
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Langerhans' cells in oral lichen planus using monoclonal antibodies.
Sloberg K; Jonsson R; Jontell M
J Oral Pathol; 1984 Oct; 13(5):516-24. PubMed ID: 6434718
[TBL] [Abstract][Full Text] [Related]
13. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
Aberer W; Kruisbeek AM; Shimada S; Katz SI
J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
[TBL] [Abstract][Full Text] [Related]
14. Methods in laboratory investigation. Immunoelectron microscopic methods for demonstration of antigens on normal human melanocytes and other epidermal cells.
van Duinen SG; Mauw BJ; de Graaff-Reitsma CB; Ruiter DJ
Lab Invest; 1984 Jun; 50(6):733-41. PubMed ID: 6427521
[TBL] [Abstract][Full Text] [Related]
15. Isolation of epidermal Langerhans cells.
Morhenn VB; Pfendt EA
Methods Enzymol; 1984; 108():357-62. PubMed ID: 6396484
[No Abstract] [Full Text] [Related]
16. [Value of correlated immunofluorescence and immunoperoxidase study of monoclonal markers in 2 adult cases of histiocytosis X].
Dreno B; Milpied B; Mousset S; Pecquet C; Murat A; Bureau B; Litoux P; Barrière H
Ann Dermatol Venereol; 1984; 111(1):31-6. PubMed ID: 6375521
[TBL] [Abstract][Full Text] [Related]
17. Identification of Langerhans cells: simultaneous use of sera to intermediate filaments, T6 and HLA-DR antigens on oral mucosa, human epidermis and their tumours.
Löning T; Caselitz J; Seifert G; Weber K; Osborn M
Virchows Arch A Pathol Anat Histopathol; 1982; 398(2):119-28. PubMed ID: 6819705
[TBL] [Abstract][Full Text] [Related]
18. Recent advances of ultrastructural immunocytochemistry of epidermal Langerhans cells.
Schmitt D; Dezutter-Dambuyant C; Faure M; Thivolet J
Br J Dermatol; 1985 Jul; 113 Suppl 28():2-9. PubMed ID: 3925979
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural documentation of HLA-DR antigen reactivity in normal human acrosyringial epithelium.
Murphy GF; Shepard RS; Harrist TJ; Bronstein BR; Bhan AK
J Invest Dermatol; 1983 Aug; 81(2):181-3. PubMed ID: 6348181
[TBL] [Abstract][Full Text] [Related]
20. Loss of allogeneic T-cell activating ability and Langerhans cell markers in human epidermal cell cultures.
Demidem A; Faure M; Dezutter-Dambuyant C; Thivolet J
Clin Immunol Immunopathol; 1986 Mar; 38(3):319-26. PubMed ID: 2935342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
